Competitive
Monitor how competitors respond to market openings, data releases, and regulatory milestones across key franchises.
4 signals
COMPETITIVE
Bruceine D epigenetically restores SMAD3 expression and suppresses malignant progression in EGFR-TKI-resistant lung adenocarcinoma.
COMPETITIVE
A bibliometric analysis reveals a significant growth in CAR-T cell therapy research for acute lymphoblastic leukemia, with a focus on long-term outcomes and risk assessment.
COMPETITIVE
A new infrastructure is being proposed to support the development of mobile health tools aimed at reducing smoking among cancer patients.
COMPETITIVE
Compound 7a is a highly selective CDK7 inhibitor with an IC50 of 1.9 nM, demonstrating significant antitumor efficacy in HCT116 models.
Showing 1–4 of 4 records
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.